LYRM2 and hepatocellular carcinoma: After investigating cells carrying nonshared immunogenic peptide‐related mutation (HEBP1) and cells carrying shared immunogenic peptide‐related mutation (LYRM2) in HCC 277, we observed that cells with LYRM2 mutation exhibited relatively high frequency and broad distribution at single cell level (Figure 6G).